Nasopharyngeal carcinoma in childhood and adolescence: Concept and preliminary results of the cooperative GPOH study NPC-91

Cancer

Volumn 80, Issue 5, 1997, Pages 951-959

  Mertens, Rolf ^a   Granzen, Bernd ^a   Lassay, Lisa ^a   Gademann, Günther ^b   Hess, Clemens F ^c   Heimann, Gerhard ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Chemotherapy; Childhood; Interferon ; Nasopharyngeal carcinoma; Radiation therapy

Indexed keywords

BETA INTERFERON; CISPLATIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

ADOLESCENT; ARTICLE; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CARDIOTOXICITY; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MUCOSA INFLAMMATION; NASOPHARYNX CARCINOMA; NAUSEA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; VOMITING;

ADENOCARCINOMA, CLEAR CELL; ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CHILD; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; INTERFERON-BETA; MALE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PREMEDICATION; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0030808024     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970901)80:5<951::AID-CNCR18>3.0.CO;2-V     Document Type: Article

References (52)

1. Berry MP, Smith CR, Brown TC, Jenkin T, Rider WD. Nasopharyngeal carcinoma in the young. Int J Radiat Oncol Biol Phys 1980;6:415-21.
2. Quin D, Yuhua H, Jiehuaa Y,Guozhen X, Weiming C, Xuelin W, et al. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer 1988; 61:1117-24.
3. Ellouz R, Cammoun M, Attia RB, Bahi J. Nasopharyngeal carcinoma in children and adolescents in Tunisia: clincal aspects and the paraneoplastic syndrome. WHO-IARC Science Publication 1978;20:115-29.
4. Hidayatalla A, Malikk MOS, El-Haadi AE. Studies on nasopharyngeal carcinoma in the Sudan. Eur J Cancer Clin Oncol 1983;19:705-10.
5. Wolf H, zur Hausen H, Becher Y. EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol 1973;244:244-5.
6. Baker SD, Mc Clatchey KD. Carcinoma of the nasopharynx in childhood. Otolarynology 1981;89:555-9.
7. Fernandez C, Cangir A, Samaan A, Rivera R. Nasopharyngeal carcinoma in children. Cancer 1976;37:2787-91.
8. Huang TB. Cancer of the nasopharynx in childhood. Cancer 1990;66:968-71.
9. Krueger GRF, Wustrow J. Current classification of nasopharyngeal carcinoma at Cologne University. In: Grundmanna E, Krueger GRF, Ablashi DV, editors. Nasopharyngeal carcinoma. Volume 5. Stuttgart: Gustav Fischer Verlag, 1981:11-5.
10. Micheau C, De The G, Orofiamma B, Schwaab G, Brugere J, Tursz T, et al. Practical value of classifiying nasopharynx carcinoma in two major microscopical types. In: Grundmann E, Krueger GRF, Ablashi DV, editors. Nasopharyngeal carcinoma. Volume 5. Stuttgart: Gustav Fischer Verlag; 1981:51-7.
11. Pearson GR, Weiland LH, Neel HB, Taylor W, Earle J, Mulroney E, et al. Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma. Cancer 1983;51:260-8.
12. Raab-Traub N. Epstein-Barr virus and nasopharyngeal carcinoma. Semin Cancer Biol 1992;3:297-307.
13. Bornkamm GW. Virologisch-serologische Diagnostik des Nasopharynxkarzinoms. In: Wannenmacker M, editor. Nasopharynx-Tumoren. Urban und Schwarzenberg, München: 1984:15-21.
14. Henle W, Henle G. The Association of EBV with nasopharyngeal carcinoma. In: Grundmann E, Krueger GRF, Ablashi DV, editors. Nasopharyngeal carcinoma. Volume 5. Stuttgart: Gustav Fischer Verlag, 1981:1-5.
15. Naegele RF, Champion J, Murphy S, Henle G, Henle W. Nasopharyngeal carcinoma in American children: Epstein-Barr virus-specific antibody titers and prognosis. Int J Cancer 1982;29:209-12.
16. Sham J, Choy D, Kwong PW, Cheng AC, Kwong DL, Yau CC, et al. Radiotherapy for nasopharyngeal carcinoma: shielding the pituitary may improve therapeutic ratio, Int J Radiat Oncol Biol Phys 1994;29:699-704.
17. Ho JHC. Stage classification of nasopharyngeal carcinoma : a review. In: De-The G, Ito Y, editors. Nasopharyngeal carcinoma : etiology and control. Volume 20. Lyon: IARC Scientific Publications, 1978:99-113.
18. Lobo-Sanahuja F, Garcia I, Carranza A, Cmacho A. Treatment and outcome of undifferentiated carcinoma of the nasopharynx in childhood: a 13-year experience. Med Pediatr Oncol 1986;14:6-11.
19. Blutters-Sawatzki R, Grathwohl J, Mertens R, Lampert F. Severe cardiotoxicity of high-dose 5-fluorouracil in combination with folinic acid, cisplatin and methotrexate in a 14-year-old boy with nasopharyngeal carcinoma (Schmincke tumor). Oncology 1995;52:291-4.
20. Mertens R, Karstens JH, Ammon J, Classen HWW, Mittermayer C. Bisherige Erfahrungen der Interferontherapie an 7 Patienten mit NPC. In: Wannenmacher M, editor. Nasopharynxtumoren. München: Urban und Schwarzenberg, 1984:188-93.
21. Castro-Vita HC, Mendiondo DL, Shaw DL, Jelden G, Rene JB, Frias Z, et al. Nasopharyngeal carcinoma in the second decade of life. Radiology 1983;148:253-6.
22. Jereb B, Huvos AG, Steinherz P, Unal A. Nasopharyngeal carcinoma in children: review of sixteen cases. Int J Radiat Oncol Biol Phys 1980;6:487-92.
23. Kaasa S, Kragh-Jensen E, Bjordal K, Lund E, Evensen JE, Vermund H, et al. Prognostic factors in patients with nasopharyngeal carcinoma. Acta Oncol 1993;32:531-6.
24. Sham JS, Poon YF, Wei WI, Choy D. Nasopharyngeal carcinoma in young patients. Cancer 1990;65:2606-10.
25. Sarrazin D, Schwaab G, Fontaine F, Kalifa C, Richard J, Archambault R. Radiotherapy of carcinoma of the nasopharynx in children after previous chemotherapy: preliminary results on 21 cases treated at the Institut Gustave-Roussy between1978 and 1981. Ann Otolaryngol Chir Cervicofac 1985;3:1175-8.
26. Gasparini M, Lombardi F, Rottoli L, Ballerini E, Morandi F. Combined radiotherapy and chemotherapy in Stage T3 and T4 nasopharyngeal carcinoma in children. J Clin Oncol 1988;6:491-4.
27. Pao WJ, Hustu HO, Douglass EC, Beckford NS, Kun LE. Pediatric nasopharyngeal carcinoma: long term follow-up of 29 patients. Int J Radiat Oncol Biol Phys 1989;17:299-305.
28. Barrios NJ. Childhood nasopharyngeal carcinoma. J La State Med Soc 1993;145:151-5.
29. Kim TH, McLaren J, Alvarado CS, Wyly JB, Crocker I, Winn K, et al. Adjuvant chemotherapy for advanced nasopharyngeal carcinoma in childhood. Cancer 1989;63:1922-6.
30. Lombardi F, Gasparini M, Gianni C, De Marie M, Molinari R, Pilotti S. Nasopharyngeal carcinoma in childhood. Med Pediatr Oncol 1982;10:243-50.
31. Morales P, Bosch A, Salaverry S, Corea JN, Martinez I. Cancer of nasopharynx in young patients. J Surg Oncol 1984;27:181-5.
32. Zaghloul MS, Dahaba NM, Wahab AA, Hussein MH, el-Koutbey M. Nasopharyngeal carcinoma in children and adolescents: successful role of retrieval therapy. Tumori 1993; 79:123-7.
33. Rossi A, Molinari R, Nava M, Felci U, Del Vecchio M, De Palo G. Nasopharynx carcinoma in childhood. Proc Am Soc Clin Oncol 1985;142:554.
34. Jenkin DR, Anderson JR, Jereb B,Thompson JC, Pyesmany A, Wara WM, et al. Nasopharyngeal carcinoma: a retrospective review of patients less than thirty years of age. Cancer 1981;47:360-6.
35. Martin WD, Shah KJ. Carcinoma of the nasopharynx in young patients. Int J Radiat Oncol Biol Phys 1994;28:991-9.
36. Arush MW, Stein ME, Rosenblatt E, Lavie R, Kuten A. Advanced nasopharyngeal carcinoma in the young: the Northern Israel Oncology Center experience, 1973-91. Pediatr Hematol Oncol 1995;12:271-6.
37. Dimery IW, Peters LJ, Goepfert H, Morrison H, Byers RM, Guillory C, et al. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma. J Clin Oncol 1993;11:1919-28.
38. Douglass EC, Fontanesi J, Ribeiro RC, Hawkins E. Improved long-term disease-free survival in nasopharyngeal carcinoma ( NPC ) in childhood and adolescence. Proc Am Soc Clin Oncol 1996;15:467.
39. De-en H, Ling XS, Hu J, Li B, Wang XF, Shen Y, Ye J. The effects of radiotherapy on the immune system of patients with nasopharyngeal carcinoma. Br J Radiol 1988;61:305-8.
40. Karran L, Jones M, Morley G, van Noorden S, Smith P, Lampert J, et al. Expression of a B-cell marker, CD24, on nasopharyngeal carcinoma cells. Int J Cancer 1995;60:562-6.
41. Huang ES, Gutsch D, Tzung KW, Lin CT. Detection of low level of human papilloma virus type 16 DNA sequences in cancer cell lines derived from two well-differentiated nasopharyngeal cancers. J Med Virol 1993;40:244-50.
42. Tamura S, Yamazaki A, Kunimoto M, Takemura M, Tabata T, Hinuma Y, et al. Impaired long-term T cell immunity to Epstein-Barr virus in patients with nasopharyngeal carcinoma. Jpn J Cancer Res 1992;83:445-9.
43. Tsukuda M, Sawaki S, Yanoma S. Suppressed cellular immunity in patients with nasopharyngeal carcinoma. J Cancer Res Clin Oncol 1993;120:115-8.
44. Fleischmann R, Fleischmann M. Mechanisms of interferons' antitumor agents. In: Interferon: principles and medical applications. Galveston, TX: University of Texas Medical Branch, 1992:299-308.
45. Bertram G. Nasopharyngeal carcinoma (NPC): the influence of different types of interferon (JFN) to peripheral cellular immunity. J Exp Clin Cancer Res 1988;7:3.
46. Mertens R, Lassay L, Heimann G. Combined treatment of nasopharyngeal cancer in children and adolescents: concept of a study. Klin Padiatr 1993;205:241-8.
47. Treuner J, Niethammer D, Dannecker G, Hagmann R, Neef V, Hofschneider PH. Successful treament of nasopharyngeal carcinoma with interferon. Lancet 1980;12:817-8.
48. Mahjoubi R, Bachouchi M, Munck JN, Busson P, Gasmi J, Azli N, et al. Phase II trial of recombinant interferon gamma in refractory undifferentiated carcinoma of the nasopharynx. Head Neck 1993;15:115-8.
49. Conners JM, Andiman WA, Howarth CB, Jacobs C. Treatment of nasopharyngeal carcinoma with human leucoyte IFN. J Clin Oncol 1985;3:813-7.
50. Furukawa M. Treatment and clinical results of nasopharyngeal carcinoma with interferon beta and its effects on Epstein-Barr virus (EBV) serology. Otolaryngology 1984;56:899-903.
51. Mertens R, Karstens JH, Bertram G, Ammon J. Kombinierte Behandlungsverfahren bei Patienten mit einem NPC. Zentralbl Radiol 1985;128:76-9.
52. Treuner J, Niethammer D, Dannecker G, Jobke A, Aldenhoff P, Kremenz B, et al. Treatment of nasopharyngeal carcinoma in children with fibroblast IFN. In: Grundmann E, Krueger GRF, Ablashi DV, editors. Nasopharyngeal carcinoma. Volume 5. Stuttgart: Gustav Fischer Verlag, 1981:309-18.